DRUG

BRIGHT MINDS BIOSCIENCES INC

DRUG·10919W405·US·Common Stock·Healthcare - Biotechnology-Activist

DRUG (BRIGHT MINDS BIOSCIENCES INC) is held by 61 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($48.2M), DRIEHAUS CAPITAL MANAGEMENT LLC ($30.4M), BALYASNY ASSET MANAGEMENT L.P. ($24.2M). Net institutional sentiment: Bullish.

61
Holders
(1 Elite)
$264M
Total Value
81% (63)
Consensus
51 buying - 12 selling
13F: Insider & Congress: Updated regularly
DRUG

Smart Money Verdict

View all
Loading verdict
Held by 61 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Apr 30, 2026 · Activists Aug 14, 2026 · Congress none

ActivistCACormorant Asset Management, LP9.2%Aug 14, 2026
ActivistADAdage Capital Management, L.P.3.4%Aug 12, 2026
ActivistIMIan McDonald13.7%Jul 2, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
686,184(+10.3%)$48.2M0.0%+21.37%
32
Increased
433,377(+0.2%)$30.4M0.2%-5.93%
34
Increased
345,053(+16.1%)$24.2M0.0%+10.38%
33
Decreased
335,000(-32.4%)$23.5M0.0%+35.73%
0
New
327,416$23M0.0%+3.72%
39
Unchanged
265,000$18.6M0.2%-8.99%
0
Increased
171,315(+25.3%)$12M0.0%-6.28%
34
Increased
133,689(+79.8%)$9.4M0.0%-1.80%
42
Increased
122,178(+12.9%)$8.6M0.0%+23.28%
31
Increased
104,146(+17.4%)$7.3M0.0%+55.22%
32
Increased
80,060(+32.4%)$5.6M0.0%-6.18%
35
Increased
70,615(+847.7%)$5M0.0%+2.21%
43
Increased
66,740(+26.3%)$4.7M0.0%+16.66%
33
New
66,533$4.7M0.0%+3.72%
37
Increased
66,277(+400.4%)$4.7M0.0%+14.60%
43
Increased
66,106(+23.1%)$4.6M0.0%+14.76%
33
Unchanged
45,668$3.2M0.0%-8.99%
0
Increased
42,466(+13.6%)$3M0.0%+58.74%
30
Decreased
37,902(-24.2%)$2.7M0.0%-8.99%
0
New
35,747$2.5M0.0%+3.72%
36

Showing 1-20 of 69

1 / 4
DRUGDRUGBRIGHT MINDS BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used